New diabetes drug goes Head-to-Head with standard insulin
NCT ID NCT07018453
Summary
This study is testing whether a new drug called SHR-3167 works as well as a standard insulin treatment for controlling blood sugar in people with type 2 diabetes. Researchers will compare both treatments in 173 adults who are already using insulin with or without other diabetes pills. The main goal is to see which treatment better lowers long-term blood sugar levels over time.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES MELLITUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The First Affiliated Hospital of Chongqing Medical University
Chongqing, Chongqing Municipality, 400000, China
-
Zhongshan Hospital Affiliated to Fudan University
Shanghai, Shanghai Municipality, 200032, China
Conditions
Explore the condition pages connected to this study.